In Silico Biosystem Model for Cellular Behavior Prediction

The patent segments the complex biochemical reaction network into modular components: genes, gene products, and chemical reactions are separated into distinct functional units. This segmentation allows the system to analyze and predict effects of perturbations on specific components without being overwhelmed by the entire complex network, thereby improving prediction accuracy while managing complexity.

The patent introduces an in silico model as an intermediary between the complex biochemical system and the researcher. This virtual model serves as a mediator that simulates cellular behavior and predicts the effects of perturbations, allowing accurate predictions to be made without directly analyzing the full complexity of the actual biochemical network.

The patent creates a virtual copy (in silico model) of the biosystem that replicates the interconnected behavior of genes, gene products, and chemical reactions. This digital twin allows researchers to study the integrated perspective of cellular behavior and predict outcomes of perturbations without being constrained by the computational complexity of the actual biological system's interconnectivity.

The patent utilizes parameter changes in the in silico model to simulate different conditions and perturbations. By systematically varying parameters such as gene expression levels, enzyme activities, and environmental conditions, the model can predict how changes propagate through the interconnected biosystem, enabling efficient process optimization without manually analyzing every interconnection.

The patent incorporates feedback mechanisms in the in silico model by continuously comparing model predictions with experimental data. This feedback loop allows the model to be refined and updated, improving its accuracy in predicting cellular behavior. As the model becomes more accurate, the time required for drug development is reduced because fewer iterations of testing and refinement are needed.

The patent enables preliminary action by using the in silico model to predict the effects of potential drug compounds and perturbations before actual experimental testing. This virtual screening and prediction process identifies promising candidates and eliminates unlikely options in advance, significantly reducing the time required for subsequent experimental development and validation.